Controversies and litigations threaten to derail a sector that once saw immense potential in India.

The recently-announced "free drugs for all" initiative by the Centre could lead to the long-pending national pharmaceutical policy getting cleared.

The $7.8-billion US-based medical technology major Becton Dickinson (BD), is in the final stages of developing a new technology for diagnosing tuberculosis (TB), which kills 300,000 Indians every y